Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Income from Continuing Operations (2016 - 2025)

Apyx Medical's Income from Continuing Operations history spans 15 years, with the latest figure at 1240000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 82.57% year-over-year to 1240000.0; the TTM value through Dec 2025 reached 11105000.0, up 57.31%, while the annual FY2025 figure was 11105000.0, 57.31% up from the prior year.
  • Income from Continuing Operations reached 1240000.0 in Q4 2025 per APYX's latest filing, up from 1955000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1019000.0 in Q2 2023 to a low of 9624000.0 in Q4 2023.
  • Average Income from Continuing Operations over 5 years is 4722350.0, with a median of 4699500.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: crashed 546.32% in 2024, then skyrocketed 82.57% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 2010000.0 in 2021, then crashed by 201.74% to 6065000.0 in 2022, then crashed by 58.68% to 9624000.0 in 2023, then grew by 26.08% to 7114000.0 in 2024, then surged by 82.57% to 1240000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Income from Continuing Operations are 1240000.0 (Q4 2025), 1955000.0 (Q3 2025), and 3738000.0 (Q2 2025).